Pembrolizumab vs Nivolumab as Initial Treatment for Advanced, Unresectable, or Metastatic Melanoma. (PubMed, JAMA Netw Open) - Sep 30, 2026 - No abstract available
Journal • Melanoma • Oncology • Solid Tumor
|
|
Alex K Bryant; Daniel A Goldstein; Garth W Strohbehn; Josiah D Nieto
|